Header Ads

AstraZeneca’s COVID-19 vaccine candidate begins late-stage U.S. study

September 01, 2020
AstraZeneca Plc said on Monday it has begun enrolling adults for a U.S.-funded, 30,000-subject late-stage study of its high profile COVID-19 vaccine candidate. Read More

from Canoe https://ift.tt/34XrXS2

Post a Comment

No comments

Subscribe to: Post Comments ( Atom )